Format

Send to

Choose Destination
Stem Cells Transl Med. 2017 Jan;6(1):14-16. doi: 10.5966/sctm.2016-0208. Epub 2016 Aug 2.

The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar.

Author information

1
Department of Cell Biology and Human Anatomy, University of California Davis School of Medicine, Davis, California, USA.
2
Genome Center, University of California Davis School of Medicine, Davis, California, USA.
3
Institute of Pediatric Regenerative Medicine, Shriners Hospital for Children Northern California, Sacramento, California, USA.

Abstract

The growing direct-to-consumer, stem cell clinic industry in the U.S. uses a number of strategies for patient recruitment, including self-styled educational seminars, which may reach thousands of members of the public annually. Here I report on a first-hand experience at such a seminar that I recently attended. Numerous specific medical claims were made at the seminar: no potential for rejection; no side effects, including no pain; proven efficacy for a variety of conditions, including in particular arthritis and pain; and U.S. Food and Drug Administration approval. I discuss the potential impact of these kinds of seminars on the public and on the stem cell field. Stem Cells Translational Medicine 2017;6:14-16.

PMID:
28170181
PMCID:
PMC5442738
DOI:
10.5966/sctm.2016-0208
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center